156 related articles for article (PubMed ID: 15302635)
1. Outcomes and cost of deep venous thrombosis among patients with cancer.
Elting LS; Escalante CP; Cooksley C; Avritscher EB; Kurtin D; Hamblin L; Khosla SG; Rivera E
Arch Intern Med; 2004 Aug 9-23; 164(15):1653-61. PubMed ID: 15302635
[TBL] [Abstract][Full Text] [Related]
2. Use of inferior vena caval filters and survival in patients with malignancy.
Wallace MJ; Jean JL; Gupta S; Eapen GA; Johnson MM; Ahrar K; Madoff DC; Morello FA; Murthy R; Hicks ME
Cancer; 2004 Oct; 101(8):1902-7. PubMed ID: 15386336
[TBL] [Abstract][Full Text] [Related]
3. Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery.
Nutescu EA; Shorr AF; Farrelly E; Horblyuk R; Happe LE; Franklin M
Ann Pharmacother; 2008 Sep; 42(9):1216-21. PubMed ID: 18611992
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic outcomes in thrombolytic treatment of peripheral arterial occlusive disease and deep venous thrombosis.
Ouriel K; Kaul AF; Leonard MC
J Vasc Surg; 2004 Nov; 40(5):971-7. PubMed ID: 15557913
[TBL] [Abstract][Full Text] [Related]
5. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS
Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment model for venothromboembolism in post-hospitalized patients.
Yale SH; Medlin SC; Liang H; Peters T; Glurich I; Mazza JJ
Int Angiol; 2005 Sep; 24(3):250-4. PubMed ID: 16158034
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
Andreozzi GM
Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
[TBL] [Abstract][Full Text] [Related]
8. The effect of deep venous thrombosis on short-term outcomes and cost of care after head and neck cancer surgery.
Hennessey P; Semenov YR; Gourin CG
Laryngoscope; 2012 Oct; 122(10):2199-204. PubMed ID: 22865644
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study.
Galanaud JP; Sevestre-Pietri MA; Bosson JL; Laroche JP; Righini M; Brisot D; Boge G; van Kien AK; Gattolliat O; Bettarel-Binon C; Gris JC; Genty C; Quere I;
Thromb Haemost; 2009 Sep; 102(3):493-500. PubMed ID: 19718469
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
11. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.
Secin FP; Jiborn T; Bjartell AS; Fournier G; Salomon L; Abbou CC; Haber GP; Gill IS; Crocitto LE; Nelson RA; Cansino Alcaide JR; Martínez-Piñeiro L; Cohen MS; Tuerk I; Schulman C; Gianduzzo T; Eden C; Baumgartner R; Smith JA; Entezari K; van Velthoven R; Janetschek G; Serio AM; Vickers AJ; Touijer K; Guillonneau B
Eur Urol; 2008 Jan; 53(1):134-45. PubMed ID: 17597288
[TBL] [Abstract][Full Text] [Related]
12. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
13. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.
Russell MW; Taylor DC; Cummins G; Huse DM
Am J Manag Care; 2002 Jan; 8(1 Suppl):S3-9. PubMed ID: 11822347
[TBL] [Abstract][Full Text] [Related]
14. Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program.
Groce JB
Pharmacotherapy; 1998; 18(6 Pt 3):175S-180S. PubMed ID: 9853912
[TBL] [Abstract][Full Text] [Related]
15. [Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients].
Sun KK; Wang C; Pang BS; Yang YH; He W; Chen TF; Zhao QH; Zhang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1019-23. PubMed ID: 15769354
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States.
Caprini JA; Botteman MF; Stephens JM; Nadipelli V; Ewing MM; Brandt S; Pashos CL; Cohen AT
Value Health; 2003; 6(1):59-74. PubMed ID: 12535239
[TBL] [Abstract][Full Text] [Related]
17. Home-treatment of deep vein thrombosis in patients with cancer.
Ageno W; Grimwood R; Limbiati S; Dentali F; Steidl L; Wells PS
Haematologica; 2005 Feb; 90(2):220-4. PubMed ID: 15710575
[TBL] [Abstract][Full Text] [Related]
18. Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital.
Lee M; Pao D; Hsu T; Sonderskov A
Can J Clin Pharmacol; 2004; 11(1):e17-27. PubMed ID: 15226523
[TBL] [Abstract][Full Text] [Related]
19. Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event.
Mahan CE; Holdsworth MT; Welch SM; Borrego M; Spyropoulos AC
Thromb Haemost; 2011 Sep; 106(3):405-15. PubMed ID: 21833446
[TBL] [Abstract][Full Text] [Related]
20. Deep venous thrombosis in children and adolescents.
Levy ML; Granville RC; Hart D; Meltzer H
J Neurosurg; 2004 Aug; 101(1 Suppl):32-7. PubMed ID: 16206969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
